Clinical Trials List
Protocol Number232SM201
Completed
2015-01-26 - 2025-06-02
Phase II
Terminated2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 謝正宜 Division of Pediatrics
- WEN-CHIN WENG Division of Pediatrics
- WUH-LIANG HWU Division of Pediatrics
- WANG-TSO LEE Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
25 participants
